Light
Dark
System
Log In
Loading...
Compare / EASA/
Incorporated Amendments
/
Compare & Highlight Differences
AMC2 MED.B.015 Respiratory system
Available versions for ERULES-1963177438-11217
ED Decision 2019/002/R
found in: Aircrew (1178/2011) Part-FCL Part-MED Part-CC Part-ARA Part-ORA Part-DTO (Dec 2024)
From
Aircrew (1178/2011... (Nov 2025)
Aircrew (1178/2011... (Dec 2024)
Aircrew (1178/2011... (Aug 2023)
From section
To
Aircrew (1178/2011... (Nov 2025)
Aircrew (1178/2011... (Dec 2024)
Aircrew (1178/2011... (Aug 2023)
To section
No visible text changes
0 removals
0 additions
View
Rich
Plain
Sync scrolling
Share
From
Show details
Hide details
To
Show details
Hide details
Version
Show side by side
AMC2 MED.B.015 Respiratory system ED Decision 2019/002/R (a) Examination (1) A spirometric examination should be performed on clinical indication. Applicants with a forced expiratory volume in the first one second (FEV1)/forced vital capacity(FVC)ratio of less than 70 % should be evaluated by a specialist in respiratory disease. (2) Posterior/anterior chest radiography may be required if clinically or epidemiologically indicated. (b) Chronic obstructive pulmonary disease Applicants with only minor impairment of pulmonary function may be assessed as fit. (c) Asthma Applicants with asthma may be assessed as fit if the asthma is considered stable with satisfactory pulmonary function tests and medication is compatible with flight safety. Applicants requiring systemic steroids should be assessed as unfit. (d) Inflammatory disease Applicants with active inflammatory disease of the respiratory system should be assessed as unfit pending resolution of the condition. (e) Sarcoidosis (1) Applicants with active sarcoidosis should be assessed as unfit. Investigation should be undertaken with respect to the possibility of systemic involvement. A fit assessment may be considered once the disease is inactive. (2) Applicants with cardiac sarcoid should be assessed as unfit. (f) Pneumothorax (1) Applicants with spontaneous pneumothorax should be assessed as unfit. A fit assessment may be considered if respiratory evaluation is satisfactory: (i) six weeks following full recovery from a single spontaneous pneumothorax; (ii) following surgical intervention in the case of a recurrent pneumothorax, provided there is satisfactory recovery. (2) A fit assessment following full recovery from a traumatic pneumothorax as a result of an accident or injury may be acceptable once full absorption of the pneumothorax is demonstrated. (g) Thoracic surgery Applicants requiring major thoracic surgery should be assessed as unfit until recovery is complete, the applicant is asymptomatic, and the risk of secondary complication is minimal. (h) Sleep apnoea syndrome Applicants with unsatisfactorily treated sleep apnoea syndrome should be assessed as unfit.
AMC2 MED.B.015 Respiratory system ED Decision 2019/002/R (a) Examination (1) A spirometric examination should be performed on clinical indication. Applicants with a forced expiratory volume in the first one second (FEV1)/forced vital capacity(FVC)ratio of less than 70 % should be evaluated by a specialist in respiratory disease. (2) Posterior/anterior chest radiography may be required if clinically or epidemiologically indicated. (b) Chronic obstructive pulmonary disease Applicants with only minor impairment of pulmonary function may be assessed as fit. (c) Asthma Applicants with asthma may be assessed as fit if the asthma is considered stable with satisfactory pulmonary function tests and medication is compatible with flight safety. Applicants requiring systemic steroids should be assessed as unfit. (d) Inflammatory disease Applicants with active inflammatory disease of the respiratory system should be assessed as unfit pending resolution of the condition. (e) Sarcoidosis (1) Applicants with active sarcoidosis should be assessed as unfit. Investigation should be undertaken with respect to the possibility of systemic involvement. A fit assessment may be considered once the disease is inactive. (2) Applicants with cardiac sarcoid should be assessed as unfit. (f) Pneumothorax (1) Applicants with spontaneous pneumothorax should be assessed as unfit. A fit assessment may be considered if respiratory evaluation is satisfactory: (i) six weeks following full recovery from a single spontaneous pneumothorax; (ii) following surgical intervention in the case of a recurrent pneumothorax, provided there is satisfactory recovery. (2) A fit assessment following full recovery from a traumatic pneumothorax as a result of an accident or injury may be acceptable once full absorption of the pneumothorax is demonstrated. (g) Thoracic surgery Applicants requiring major thoracic surgery should be assessed as unfit until recovery is complete, the applicant is asymptomatic, and the risk of secondary complication is minimal. (h) Sleep apnoea syndrome Applicants with unsatisfactorily treated sleep apnoea syndrome should be assessed as unfit.
##### AMC2 MED.B.015 Respiratory system *ED Decision 2019/002/R* (a) Examination (1) A spirometric examination should be performed on clinical indication. Applicants with a forced expiratory volume in the first one second (FEV1)/forced vital capacity(FVC)ratio of less than 70 % should be evaluated by a specialist in respiratory disease. (2) Posterior/anterior chest radiography may be required if clinically or epidemiologically indicated. (b) Chronic obstructive pulmonary disease Applicants with only minor impairment of pulmonary function may be assessed as fit. (c) Asthma Applicants with asthma may be assessed as fit if the asthma is considered stable with satisfactory pulmonary function tests and medication is compatible with flight safety. Applicants requiring systemic steroids should be assessed as unfit. (d) Inflammatory disease Applicants with active inflammatory disease of the respiratory system should be assessed as unfit pending resolution of the condition. (e) Sarcoidosis (1) Applicants with active sarcoidosis should be assessed as unfit. Investigation should be undertaken with respect to the possibility of systemic involvement. A fit assessment may be considered once the disease is inactive. (2) Applicants with cardiac sarcoid should be assessed as unfit. (f) Pneumothorax (1) Applicants with spontaneous pneumothorax should be assessed as unfit. A fit assessment may be considered if respiratory evaluation is satisfactory: (i) six weeks following full recovery from a single spontaneous pneumothorax; (ii) following surgical intervention in the case of a recurrent pneumothorax, provided there is satisfactory recovery. (2) A fit assessment following full recovery from a traumatic pneumothorax as a result of an accident or injury may be acceptable once full absorption of the pneumothorax is demonstrated. (g) Thoracic surgery Applicants requiring major thoracic surgery should be assessed as unfit until recovery is complete, the applicant is asymptomatic, and the risk of secondary complication is minimal. (h) Sleep apnoea syndrome Applicants with unsatisfactorily treated sleep apnoea syndrome should be assessed as unfit.